Governance Novartis AG

NOVN

CH0012005267

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 10:01:52 16/01/2026 pm IST			5-day change	1st Jan Change
115.60 ^CHF	+0.98%		+1.37%	+5.47%

16/01	Novartis Ianalumab Receives Fda Breakthrough Therapy Designation for Sjogren's Disease	CI
16/01	Novartis Receives US FDA Breakthrough Therapy Designation for Ianalumab to Treat Sjogren's Disease	MT

Executive Committee: Novartis AG

Manager

Positions heldSince

Vasant Narasimhan

50 year

Chief Executive Officer

01/02/2018

Teresa Jose

Comptroller/Controller/Auditor

01/07/2025

Shreeram Aradhye

64 year

Chief Tech/Sci/R&D Officer

16/05/2022

Robert Kowalski

58 year

Human Resources Officer

01/09/2021

Charlotte Pamer-Wieser

Corporate Secretary

01/09/2011

Karen Hale

58 year

Compliance Officer	14/04/2025
General Counsel	15/05/2021

Steffen Lang

59 year

Chief Operating Officer

04/04/2022

Harry Werner Kirsch

61 year

Director of Finance/CFO

24/04/2013

Composition of the Board of Directors: Novartis AG

Director

CommitteesSince

Giovanni Caforio

61 year

Compensation Committee
HR Committee
Governance Committee
Nominating Committee

Bridgette Heller

64 year

Compensation Committee Chair	13/09/2019
Audit Committee	28/02/2020
Compensation Committee	28/02/2020
Governance Committee	02/02/2021
Nominating Committee	02/02/2021
Finance Committee

Nancy Andrews

67 year

Governance Committee Chair	20/05/2025
Nominating Committee Chair	20/05/2025
Compensation Committee	01/02/2021

Patrice Bula

70 year

Compensation Committee	28/02/2019
Governance Committee Chair	28/02/2019
Nominating Committee Chair	28/02/2019

Simon Moroney

67 year

Compensation Committee Chair	28/02/2020
Compensation Committee	01/04/2021
Nominating Committee	01/04/2021

Daniel Hochstrasser

66 year

Audit Committee	04/03/2022
Governance Committee	04/03/2022
Nominating Committee	04/03/2022

John Young

62 year

Audit Committee
Governance Committee
Compensation Committee	07/03/2025

Ana de Pro Gonzalo

59 year

Audit Committee	04/03/2022
Compensation Committee	04/12/2021
Audit Committee Chair	01/06/2020

Frans van Houten

65 year

Audit Committee
Governance Committee Chair
Nominating Committee Chair

Liz Doherty

69 year

Audit Committee Chair

10/05/2019

Ton Büchner

61 year

Audit Committee

02/03/2018

Elizabeth McNally

65 year

Director/Board Member

07/03/2025

Latest Appointments: Novartis AG

13/01	Swiss stocks - Factors to watch on January 13	RE
12/01	Kyverna Therapeutics, Inc. Appoints Christi Shaw as Executive Chairperson of the Board, Effective January 12, 2026	CI
08/01	Tango Therapeutics, Inc. Announces Board and Executive Changes	CI
08/01	Tango Therapeutics, Inc. Announces Chief Executive Officer Changes, Effective January 8, 2026	CI
05/01	OKYO Pharma Limited Announces Chief Executive Officer Changes, Effective January 5, 2026	CI
05/01	Gubra Announces Executive Changes	CI
24/12	Vor Biopharma Inc Announces Board Appointments, Effective December 18, 2025	CI

More news

Former Officers and Directors: Novartis AG

Insider

Positions held

SinceUntil

Srikant T. Madhav Datar

Director/Board Member	01/01/2003	01/01/2021
Independent Dir/Board Member	01/01/2003	01/01/2021

Pierre Landolt

Director/Board Member	08/01/2010	02/03/2018
Independent Dir/Board Member	08/01/2010	02/03/2018
Corporate Officer/Principal	01/01/1996	08/01/2010

Joseph Jimenez

Director/Board Member	02/11/2009	08/01/2010
Chief Executive Officer	01/02/2010	01/01/2018
Corporate Officer/Principal	08/01/2010	26/01/2010

Jürgen Brokatzky-Geiger

Human Resources Officer	01/01/2005	06/03/2014
Corporate Officer/Principal	06/03/2014	01/10/2017

Wendelin Wiedeking

Director/Board Member	01/01/2003	25/02/2014
Independent Dir/Board Member	01/01/2003	25/02/2014
Corporate Officer/Principal	01/01/2003	08/01/2010

Rolf M. Zinkernagel

Director/Board Member	08/01/2010	25/02/2014
Independent Dir/Board Member	01/01/1999	25/02/2014
Corporate Officer/Principal	01/01/1999	08/01/2010

Alexandre F. Jetzer-Chung

Director/Board Member	08/01/2010	22/02/2011
Corporate Officer/Principal	01/01/1996	08/01/2010

Raymund Breu

Director of Finance/CFO

01/12/1996

01/01/2009

Hans Jörg Reinhardt

Chief Operating Officer	01/01/2008	01/01/2010
Corporate Officer/Principal	01/01/2006	01/01/2008
Chairman	01/01/2013	07/03/2025
Independent Dir/Board Member	01/01/2013	07/03/2025

William Brody

Director/Board Member	24/02/2009	-
Independent Dir/Board Member	25/08/2011	-

Urs Bärlocher

General Counsel

01/01/1999

31/08/2007

Thomas Ebeling

Corporate Officer/Principal

01/01/2000

01/01/2007

Karen Hübscher

Public Communications Contact

01/01/2000

01/01/2006

Andreas von Planta

Director/Board Member	01/01/2006	-
Independent Dir/Board Member	01/01/2006	-

Pierre F. Dodion

Sales & Marketing

01/01/2002

01/01/2006

François Martelet

Corporate Officer/Principal

01/07/2003

01/07/2005

Ian Garland

Corporate Officer/Principal

01/06/2005

Joachim P. H. Schupp

Corporate Officer/Principal

01/01/1985

01/10/2004

Ronen Tamir

Investor Relations Contact	28/10/2011	-
Public Communications Contact	28/10/2011	-
Corporate Officer/Principal	01/01/2004	28/10/2011

Marshall E. Reese

Corporate Officer/Principal

01/01/1999

01/01/2004

Mihael Polymeropoulos

Corporate Officer/Principal

01/01/1998

01/01/2003

Gilbert Wenzel

Corporate Officer/Principal

01/11/2000

01/01/2003

Paul Herrling

Chief Tech/Sci/R&D Officer

01/11/2002

Bruce F. Fleming

Corporate Officer/Principal

01/06/2001

01/06/2002

Silke Zentner

Public Communications Contact

05/04/2002

Fredrik Ollila

Corporate Officer/Principal

01/01/2002

Paolo Baroldi

Corporate Officer/Principal

01/01/1998

01/01/2002

James New

Corporate Officer/Principal

01/01/1999

Helmut Sihler

Director/Board Member

01/01/1996

Birgit Breuel

Corporate Officer/Principal

01/01/1996

Norman Hardman

Chief Tech/Sci/R&D Officer

01/01/1996

Peter Burckhardt

Director/Board Member	31/12/2009	-
Corporate Officer/Principal	01/01/1996	31/12/2009

John McKenna

Corporate Officer/Principal

01/01/1990

Ann Bailey

Public Communications Contact

01/01/1982

Gabor Veres

Corporate Officer/Principal

Siv Lindbratt Börjes

Corporate Officer/Principal

Adrian Hunter

Corporate Officer/Principal

MaryAnn DeMarco

Corporate Officer/Principal

David Metzger

Corporate Officer/Principal

Virginia Jamieson

Corporate Officer/Principal

Max Burger

Chairman	21/04/2010	-
President	17/07/2009	21/04/2010

Ian Stuart Charles Talmage

Corporate Officer/Principal

Michael Horne

Corporate Officer/Principal

John McAdoo

Corporate Officer/Principal

Ian Matthews

Corporate Officer/Principal

Geoff MacKay

Corporate Officer/Principal

Jutta Monika Heim

Corporate Officer/Principal

Peter Thomas Sany

Chief Tech/Sci/R&D Officer

William P. Keane

Corporate Officer/Principal

Nagesh Mahanthappa

Corporate Officer/Principal

Ann Moravick

Corporate Officer/Principal

Bobby Singh

Corporate Officer/Principal

Dominique Cheneval

Corporate Officer/Principal

John H. van Duzer

Corporate Officer/Principal

Randall S. Moore

Corporate Officer/Principal

Eric Wayne Evans

Director of Finance/CFO

Christoph Hüls

Corporate Officer/Principal

Ingrid Duplain

Corporate Secretary

Bruno Heynen

Corporate Secretary

Corinne Hoff

Public Communications Contact

Stuart J. Davie

Chief Tech/Sci/R&D Officer

Günter Frankenne

Director/Board Member

Karel Petrak

Corporate Officer/Principal

Peter E. Carlin

Corporate Officer/Principal

Terry Hart

Corporate Officer/Principal

Geert C. Mudde

Corporate Officer/Principal

Phil Johnson

Corporate Officer/Principal

Malcolm B. Cheetham

Comptroller/Controller/Auditor

James Phillips

Corporate Officer/Principal

Maike July-Grolman

Corporate Officer/Principal

Armin M. Kessler

Sales & Marketing

Hans-Georg Capraro

Corporate Officer/Principal

William J. Rutter

Director/Board Member

Gordon Wright

Corporate Officer/Principal

Jeret Bode

Corporate Officer/Principal

Rob Goshert

Corporate Officer/Principal

Jeffrey Hrkach

Corporate Officer/Principal

Peter Herold

Corporate Officer/Principal

Thomas Littke

Corporate Officer/Principal

John Slevin

Corporate Officer/Principal

Cees Winnips

Corporate Officer/Principal

Humphrey Harte

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	20
Female	8

Of which Executive Committee

Male	6
Female	2

Of which Directors

Male	9
Female	3

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (29.3%); - immunology (18.5%); - cardiovascular, renal and metabolic diseases (17%); - neuroscience (9.4%). The remaining net sales (25.8%) are from contract manufacturing of pharmaceutical products. At the end of 2024, Novartis AG had over 30 production sites worldwide. Net sales are distributed geographically as follows: Europe (30.9%), the United States (42%), Asia/Africa/Australasia (20%), Canada and Latin America (7.1%).

Employees

75,883

Sector

Pharmaceuticals

Calendar

04/02 - Q4 2025 Earnings Release

More about the company